Seminar: dual use, future computing, neurorobotics in the Human Brain Project

As any other EU project, HBP is regulated to prevent research and technological development to be used for military or defense purposes (‘dual use’). Nevertheless there might be dual use interests in the project. In a two day seminar, HBP researchers and external experts met to initiate a dialogue on recognition and management of dual use issues in the HBP.

March 10, 2016 11:00 am

Citizen meeting: Privacy and data protection

Six citizen meetings were organized in order to provide the public with an opportunity to reflect on issues related to privacy and data protection in research projects, and to provide their ideas and opinions to the researchers and managers of the HBP. The meetings took place in Austria, Bulgaria, Poland, Portugal, the Netherlands and Sweden.

February 1, 2016 12:00 am

Webinar: The future computing and robotics

In an online debate on future computing and robotics external experts and HBP researchers were invited to explore the ethical, social and technical issues related to future advances in ICT, neuromorphic computing and robotics.

October 9, 2015 10:00 am

Seminar: Opening up the Human Brain Project to the neuroscience community

Researchers from the Human Brain Project (HBP) met with scientists from the neuroscience community to initiate an on-going dialogue on the data and theory for advancing the future neuroscience and the HBP.

May 21, 2015 10:00 am

Webinar: Dual use and neuroscience

During an online debate HBP researchers and experts on dual use ethics, policy and applications discussed dual use issues arising from technological development and discoveries in the Human Brain Project.

January 7, 2015 10:00 am

Webinar: Development of disease signatures and personalized medicine

The Human Brain Project (HBP) uses anonymised data from hospitals throughout Europe to discover new disease signatures for brain diseases. In an online debate experts from a variety of fields, presented their views on the social and ethical challenges associated with disease signatures and personalized medicine.

May 1, 2014 10:00 am